Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

We had a good time talking to folks last week in our ColorTokens booth at the Healthcare Information and Management Systems ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Daymond John from "Shark Tank" made a surprise appearance at a major health tech conference—and remarked on the number of ...

Health systems should ground their tech expectations in clear use cases and collaborative education, leaders shared at the ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

The brand, which entered Target just two years ago, will no longer accept orders on its website after March 24.

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it ...

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...